Biogen Inc.
$BIIB
Public valuation for Biogen Inc. (BIIB). Fair value, signal, and key metrics — no sign-in required.
Current Price
$216.06
Fairly Valued
Fair Value Estimate
$221
🏛️
Mature Growth
Profitable company with steady growth
Analyst Consensus
Target: $220.25
2% higher than current
Key Metrics
Market Cap
$31.9B
Forward P/E
15.5x
Operating Margin
16.0%
Revenue Growth
-0.8%
PEG Ratio
10.24
Get free watchlist alerts
Join the waitlist for valuation updates on $BIIB and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.